Literature DB >> 33889657

Radiomics-based assessment of idiopathic pulmonary fibrosis is associated with genetic mutations and patient survival.

Jorie D Budzikowski1, Joseph J Foy1, Ahmed A Rashid1, Jonathan H Chung1, Imre Noth2, Samuel G Armato1.   

Abstract

Purpose: The purpose of our study was to combine differences in radiomic features extracted from lung regions in the computed tomography (CT) scans of patients diagnosed with idiopathic pulmonary fibrosis (IPF) to identify associations with genetic variations and patient survival. Approach: A database of CT scans and genomic data from 169 patients diagnosed with IPF was collected retrospectively. Six region-of-interest pairs (three per lung, positioned posteriorly, anteriorly, and laterally) were placed in each of three axial CT sections for each patient. Thirty-one features were used in logistic regression to classify patients' genetic mutation status; classification performance was evaluated through the area under the receiver operating characteristic (ROC) curve [average area under the ROC curve (AUC)]. Kaplan-Meier (KM) survival curve models quantified the ability of each feature to differentiate between survival curves based on feature-specific thresholds.
Results: Nine first-order texture features and one fractal feature were correlated with TOLLIP-1 (rs4963062) mutations (AUC: 0.54 to 0.74), and five Laws' filter features were correlated with TOLLIP-2 (rs5743905) mutations (AUC: 0.53 to 0.70). None of the features analyzed were found to be correlated with MUC5B mutations. First-order and fractal features demonstrated the greatest discrimination between KM curves. Conclusions: A radiomics approach for the correlation of patient genetic mutations with image texture features has potential as a biomarker. These features also may serve as prognostic indicators using a survival curve modeling approach in which the combination of radiomic features and genetic mutations provides an enhanced understanding of the interaction between imaging phenotype and patient genotype on the progression and treatment of IPF.
© 2021 Society of Photo-Optical Instrumentation Engineers (SPIE).

Entities:  

Keywords:  MUC5B; TOLLIP; idiopathic pulmonary fibrosis; radiomics; texture analysis; thoracic computed tomography

Year:  2021        PMID: 33889657      PMCID: PMC8054271          DOI: 10.1117/1.JMI.8.3.031903

Source DB:  PubMed          Journal:  J Med Imaging (Bellingham)        ISSN: 2329-4302


  11 in total

1.  High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis.

Authors:  David A Lynch; J David Godwin; Sharon Safrin; Karen M Starko; Phil Hormel; Kevin K Brown; Ganesh Raghu; Talmadge E King; Williamson Z Bradford; David A Schwartz; W Richard Webb
Journal:  Am J Respir Crit Care Med       Date:  2005-05-13       Impact factor: 21.405

Review 2.  The Value of a Multidisciplinary Approach to the Diagnosis of Usual Interstitial Pneumonitis and Idiopathic Pulmonary Fibrosis: Radiology, Pathology, and Clinical Correlation.

Authors:  Jonathan H Chung; David A Lynch
Journal:  AJR Am J Roentgenol       Date:  2016-03       Impact factor: 3.959

3.  A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research.

Authors:  Terry K Koo; Mae Y Li
Journal:  J Chiropr Med       Date:  2016-03-31

4.  Prediction of survival by texture-based automated quantitative assessment of regional disease patterns on CT in idiopathic pulmonary fibrosis.

Authors:  Sang Min Lee; Joon Beom Seo; Sang Young Oh; Tae Hoon Kim; Jin Woo Song; Sang Min Lee; Namkug Kim
Journal:  Eur Radiol       Date:  2017-09-19       Impact factor: 5.315

5.  The real cost of sequencing: higher than you think!

Authors:  Andrea Sboner; Xinmeng Jasmine Mu; Dov Greenbaum; Raymond K Auerbach; Mark B Gerstein
Journal:  Genome Biol       Date:  2011-08-25       Impact factor: 13.583

Review 6.  Evaluating disease severity in idiopathic pulmonary fibrosis.

Authors:  Hasti Robbie; Cécile Daccord; Felix Chua; Anand Devaraj
Journal:  Eur Respir Rev       Date:  2017-09-06

7.  Idiopathic pulmonary fibrosis may be a disease of recurrent, tractional injury to the periphery of the aging lung: a unifying hypothesis regarding etiology and pathogenesis.

Authors:  Kevin O Leslie
Journal:  Arch Pathol Lab Med       Date:  2011-12-02       Impact factor: 5.534

8.  A common MUC5B promoter polymorphism and pulmonary fibrosis.

Authors:  Max A Seibold; Anastasia L Wise; Marcy C Speer; Mark P Steele; Kevin K Brown; James E Loyd; Tasha E Fingerlin; Weiming Zhang; Gunnar Gudmundsson; Steve D Groshong; Christopher M Evans; Stavros Garantziotis; Kenneth B Adler; Burton F Dickey; Roland M du Bois; Ivana V Yang; Aretha Herron; Dolly Kervitsky; Janet L Talbert; Cheryl Markin; Joungjoa Park; Anne L Crews; Susan H Slifer; Scott Auerbach; Michelle G Roy; Jia Lin; Corinne E Hennessy; Marvin I Schwarz; David A Schwartz
Journal:  N Engl J Med       Date:  2011-04-21       Impact factor: 91.245

Review 9.  Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature.

Authors:  Luba Nalysnyk; Javier Cid-Ruzafa; Philip Rotella; Dirk Esser
Journal:  Eur Respir Rev       Date:  2012-12-01

10.  TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis.

Authors:  Justin M Oldham; Shwu-Fan Ma; Fernando J Martinez; Kevin J Anstrom; Ganesh Raghu; David A Schwartz; Eleanor Valenzi; Leah Witt; Cathryn Lee; Rekha Vij; Yong Huang; Mary E Strek; Imre Noth
Journal:  Am J Respir Crit Care Med       Date:  2015-12-15       Impact factor: 21.405

View more
  1 in total

1.  Radiomics for the Prediction of Response to Antifibrotic Treatment in Patients with Idiopathic Pulmonary Fibrosis: A Pilot Study.

Authors:  Cheng-Chun Yang; Chin-Yu Chen; Yu-Ting Kuo; Ching-Chung Ko; Wen-Jui Wu; Chia-Hao Liang; Chun-Ho Yun; Wei-Ming Huang
Journal:  Diagnostics (Basel)       Date:  2022-04-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.